Ensign Peak Advisors Inc lessened its stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Rating) by 80.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,340 shares of the biopharmaceutical company’s stock after selling 101,153 shares during the quarter. […]
Swiss National Bank grew its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Rating) by 27.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 193,600 shares of the biopharmaceutical company’s stock after acquiring an additional 41,500 shares during the period. Swiss National Bank’s holdings in […]